Zhanquan Q. Li
36 Sanhao Street
Shenyang, 110004, China
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial.
Journal: Drugs
Published: December 24, 2025
Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 28, 2023
Comparison of Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Small Vessel Disease (from the Dissolve SVD Randomized Trial).
Journal: The American journal of cardiology
Published: March 16, 2023
Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China.
Journal: Lipids in health and disease
Published: January 06, 2023
Diagnostic accuracy of CT-FFR with a new coarse-to-fine subpixel algorithm in detecting lesion-specific ischemia: a prospective multicenter study.
Journal: Revista espanola de cardiologia (English ed.)
Published: December 10, 2022
Comparison between a dedicated stent positioning system and conventional stenting of aorto-ostial lesions: a prospective, multi-center, randomized controlled study.
Journal: Cardiovascular diagnosis and therapy
Published: October 26, 2022
Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-controlled Study in Chinese Patients.
Journal: Clinical therapeutics
Published: July 12, 2022
A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis.
Journal: JACC. Cardiovascular interventions
Published: April 22, 2022
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.
Journal: Circulation. Cardiovascular quality and outcomes
Published: February 02, 2022
Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: January 09, 2021
A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension.
Journal: Medicine
Published: August 10, 2020
Last Updated: 09/26/2026